Papillary mesothelioma, formally known as well-differentiated papillary mesothelioma (WDPM), is one of the rarest subtypes of mesothelioma. Unlike most forms of mesothelioma, which are aggressive and terminal, many cases of WDPM are benign or low-grade and carry a far more favorable prognosis. However, WDPM can progress to malignant mesothelioma in some patients, and accurate diagnosis is critical because the disease is frequently misdiagnosed. If you or a loved one has received a WDPM diagnosis, understanding what it means, how it differs from other mesothelioma subtypes, and what legal rights may apply is an important first step.
At The Williams Law Firm, P.C., Attorney Joseph P. Williams has never lost a mesothelioma case and has represented victims of all forms of asbestos-related disease. If your WDPM diagnosis is connected to asbestos exposure, you may be entitled to compensation.
⚠ Statute of Limitations — Your Window to File May Be Limited
New York allows 3 years from diagnosis. New Jersey allows 2. Contact us to understand your options before time expires.
Over 1,000 families represented. Hundreds of millions recovered. Never lost a mesothelioma case. No fees unless we win.
Well-differentiated papillary mesothelioma is a rare subtype of epithelioid mesothelioma. It accounts for roughly 0.3 to 5 percent of all mesothelioma cases, and there have been only approximately 200 documented cases in the medical literature since 1953. WDPM is defined by its distinctive papillary (finger-like projection) growth pattern under microscopy, which distinguishes it from the more common diffuse malignant mesothelioma.
WDPM most commonly develops in the peritoneum (the lining of the abdominal cavity) and is significantly more prevalent in women, particularly those of reproductive age, than in men. It also occurs in the pleura (lining of the lungs), the tunica vaginalis (lining of the testes), and rarely the pericardium (lining of the heart). Unlike most mesothelioma subtypes, many cases of WDPM are benign or exhibit low-grade behavior with a slow, indolent course. However, some cases do progress to frank malignant mesothelioma, and long-term monitoring is essential for all WDPM patients regardless of initial classification.
The relationship between WDPM and asbestos exposure is less clear than for other mesothelioma types. Many peritoneal WDPM cases — particularly those in younger women with no occupational history — occur without any documented asbestos exposure. However, cases associated with asbestos exposure do occur, particularly in pleural WDPM and in men. An attorney can evaluate whether an asbestos-related legal claim applies to your specific diagnosis.
WDPM is often asymptomatic and discovered incidentally during imaging or surgery performed for a different medical reason, such as an appendectomy or laparoscopy for pelvic pain. When symptoms do appear, they are typically related to fluid accumulation caused by the tumor rather than direct tissue invasion. Common symptoms include:
Unlike aggressive malignant mesothelioma, WDPM patients often do not experience severe symptoms for extended periods. The gradual and nonspecific nature of symptoms is one reason the disease is frequently discovered at an incidental exam or misattributed to other conditions before a correct diagnosis is made.
Diagnosis typically begins with a physical examination and imaging studies. CT scans and MRI scans can identify abnormal peritoneal or pleural masses or fluid accumulations. Positron emission tomography (PET) scans may be used in cases where malignancy is suspected. However, imaging alone cannot distinguish WDPM from other peritoneal or pleural tumors.
A biopsy is required for definitive diagnosis. The tissue sample is analyzed by a pathologist using histology and immunohistochemistry — a process that applies special dyes to identify specific cell proteins characteristic of mesothelial origin. The distinctive papillary architecture and the cell marker profile (typically positive for calretinin, CK5/6, WT1, and D2-40, and negative for CEA and MOC31) are necessary to confirm WDPM and distinguish it from malignant peritoneal mesothelioma, serous papillary carcinoma of the ovary, and other conditions. Because WDPM is so rare, having the pathology reviewed by a specialist with mesothelioma expertise is strongly recommended. A second opinion from a major cancer center is advisable in most cases.
WDPM is among the most misdiagnosed conditions in the mesothelioma spectrum. Its rarity means many pathologists have limited experience distinguishing it from more common look-alike diagnoses. The most frequent misdiagnoses include serous papillary carcinoma of the ovary, peritoneal carcinomatosis from a primary abdominal cancer, benign peritoneal cysts, and malignant diffuse peritoneal mesothelioma. The distinction matters enormously because the treatment pathways and prognosis differ dramatically between these conditions. An incorrect diagnosis of serous carcinoma, for example, may lead to unnecessarily aggressive treatment, while a failure to identify progression toward malignancy can leave the disease undertreated.
If you have received a WDPM diagnosis — or if you received a peritoneal or pleural diagnosis that later turned out to be incorrect — seeking a second opinion from a mesothelioma specialist is essential before beginning any treatment plan.
The prognosis for WDPM is significantly better than for other mesothelioma subtypes. Most patients with benign WDPM have an excellent long-term outlook and can live for many years or even decades after diagnosis. Deaths directly attributable to benign WDPM are rare. A case review examining patients with pleural WDPM who received multimodal treatment reported a five-year survival rate of approximately 90 percent. Patients with peritoneal WDPM had a ten-year survival rate of over 30 percent in one large case series.
However, prognosis is considerably worse in patients where WDPM progresses to frank malignant mesothelioma. Malignant transformation appears to be more common in patients with diffuse peritoneal involvement than in those with isolated or localized tumors. This is why long-term monitoring with periodic imaging is recommended for all WDPM patients, even those with initial benign classification. Any new symptoms — particularly increasing abdominal fluid, new masses, or rapid disease progression — should prompt urgent re-evaluation.
Treatment decisions for WDPM depend on whether the tumor is classified as benign or malignant and on its location. For benign WDPM with localized disease, complete surgical resection is the primary treatment and may be curative. Many patients with small, well-circumscribed benign WDPM are managed with surgery alone, with close surveillance to monitor for recurrence or malignant transformation. In some cases, surgery may not be feasible or necessary, and active monitoring is the appropriate approach.
For malignant WDPM or cases with diffuse peritoneal involvement, more aggressive treatment is required. For abdominal cases, cytoreductive surgery combined with heated intraperitoneal chemotherapy (HIPEC) has shown the most favorable outcomes among available treatments. HIPEC involves delivering chemotherapy drugs directly into the abdominal cavity at elevated temperatures immediately following surgical tumor removal, targeting residual microscopic disease that cannot be surgically excised. This approach, when performed at specialized centers, has produced meaningful long-term survival in selected patients with peritoneal mesothelioma including WDPM.
The role of systemic chemotherapy (most commonly cisplatin and pemetrexed) and radiation therapy in WDPM is less established than in malignant mesothelioma generally. Some studies have suggested that post-surgical chemotherapy does not add significant value for benign peritoneal WDPM, while others support its use in malignant or progressive cases. Given the rarity of the disease, treatment decisions should be made at a center with mesothelioma expertise where the multidisciplinary team has experience with WDPM specifically.
Yes. If your WDPM diagnosis is connected to asbestos exposure, you have the same legal rights as patients with other forms of mesothelioma. The manufacturers and distributors of asbestos-containing products, employers who exposed workers to asbestos without adequate protection, and property owners who failed to manage asbestos safely may all be liable. More than 60 asbestos bankruptcy trust funds have been established with billions of dollars to compensate victims, and these funds are accessible regardless of whether the responsible companies still exist.
Even in cases where the connection to asbestos is uncertain or where WDPM is classified as benign, the diagnosis may still support a legal claim if asbestos exposure can be documented. The presence of asbestos-related disease — even in a less aggressive form — reflects the harm caused by negligent asbestos exposure and may entitle the patient to compensation for medical monitoring, ongoing treatment costs, and other damages. In New York, the statute of limitations is three years from the date of diagnosis. In New Jersey it is two years.
Contact The Williams Law Firm, P.C. through our contact form to schedule a free consultation with our mesothelioma attorneys. You pay nothing unless we win.
★ ★ ★ ★ ★ Client Review: 5/5
“The Joseph Williams Law Office has been very kind, professional, and knowledgeable. They have helped our family through a very difficult time and I would recommend their services to anyone that needs help.”
— Lindsta Ann, Verified Client
Well-differentiated papillary mesothelioma (WDPM) is a rare subtype of epithelioid mesothelioma, accounting for approximately 0.3 to 5 percent of all mesothelioma cases. Unlike other forms of mesothelioma, which are almost always aggressive and terminal, many WDPM cases are benign or low-grade with an indolent clinical course and favorable long-term survival. It most commonly forms in the peritoneum in women of reproductive age, though it also occurs in the pleura, testes, and heart lining. Malignant transformation can occur, making long-term monitoring essential.
WDPM is often asymptomatic and found incidentally during surgery or imaging for unrelated reasons. When symptoms do occur, they are typically related to fluid accumulation and include abdominal pain, pelvic pain, abdominal swelling, shortness of breath in pleural cases, and testicular lumps or scrotal swelling in testicular cases. The symptoms are nonspecific and easily confused with other conditions, which contributes to frequent misdiagnosis.
Yes. Although most cases of WDPM are benign, some do progress to malignant mesothelioma over time, particularly when there is diffuse peritoneal involvement. This is why regular follow-up imaging and clinical monitoring are recommended for all WDPM patients, even those with an initial benign finding. Any new symptoms, expanding fluid, or new lesions on follow-up imaging should prompt urgent reassessment by a mesothelioma specialist.
Biopsy is the only definitive diagnostic method. A tissue sample is analyzed by a pathologist using histology and immunohistochemistry to identify the characteristic papillary architecture and mesothelial cell marker profile. Because WDPM is rare and frequently confused with serous papillary carcinoma and other conditions, a second opinion from a pathologist or mesothelioma center with specific experience in this subtype is strongly advisable before beginning any treatment.
Yes. If your WDPM diagnosis is connected to asbestos exposure, you may be entitled to file a personal injury lawsuit against the manufacturers of asbestos-containing products, your former employer, or other responsible parties. Asbestos bankruptcy trust fund claims are also available for qualifying patients. Even benign WDPM associated with asbestos exposure may support a legal claim for ongoing monitoring costs and other damages. The Williams Law Firm, P.C. can evaluate your specific situation in a free consultation. You pay nothing unless we win.
Get a copy of our FREE mesothelioma e-book by attorney Joseph Williams
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
CloudFlare provides web performance and security solutions, enhancing site speed and protecting against threats.
Service URL: developers.cloudflare.com (opens in a new window)
These cookies are needed for adding comments on this website.
Google Tag Manager simplifies the management of marketing tags on your website without code changes.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com (opens in a new window)
Clarity is a web analytics service that tracks and reports website traffic.
Service URL: clarity.microsoft.com (opens in a new window)
